Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.

Citation:
Baden LR, Karita E, Mutua G, Bekker L-G, Glenda Gray, Hoosen M. Coovadia, Page-Shipp L, Walsh SR, Nyombayire J, Anzala O, Roux S, Laher F, Innes C, Seaman MS, Cohen YZ, Peter L, Frahm N, McElrath JM, Hayes P, Swann E, Grunenberg N, Grazia-Pau M, Weijtens M, Sadoff J, Dally L, Lombardo A, Gilmour J, Cox J, Dolin R, Fast P, Barouch DH, Laufer DS. "Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial." Ann. Intern. Med.. 2016;164(5):313-22.

Abstract:

A prophylactic HIV-1 vaccine is a global health priority.

Notes:

n/a

UoN Websites Search